| CAS NO: | 863193-70-8 |
| 包装: | 50mg, 100mg, 250mg |
| 规格: | ≥98% |
Fenlean, formerly known as FLZ, is currently in phase I trials by Institute of Materia Medica, Chinese Academy of Medical Science as a potential treatment of Parkinson's disease. References:
纯度：≥98%
CAS：863193-70-8
m.cnreagent.com